Table 10, Randomized controlled trials included in systematic review of effect of ibandronate on fracture relative to placebo or no treatment by fracture type
Carolyn Crandall(University of California, Los Angeles), Paul G Shekelle(VA Greater Los Angeles Healthcare System), Marika J Suttorp, Roberta Shanman(RAND Corporation), Beth Roth, Sydne J Newberry, Brett Ewing, Allison Diamant(RAND Corporation), Aneesa Motala(University of Southern California), Yee-Wei Lim(RAND Corporation), Martha Timmer(RAND Corporation), Walid F. Gellad(University of Pittsburgh)
Unknown
March 1, 2012
Cited by 0
Related Papers
Validity of the Agency for Healthcare Research and Quality clinical practice guidelines: how quickly do guidelines become outdated?
|PubMed|2001|599
The effectiveness of computerized order entry at reducing preventable adverse drug events and medication errors in hospital settings: a systematic review and meta-analysis
|Systematic Reviews|2014|343
Patients' Global Ratings of Their Health Care Are Not Associated with the Technical Quality of Their Care
|Annals of Internal Medicine|2006|294
Comparative Effectiveness of Pharmacologic Treatments to Prevent Fractures
|Annals of Internal Medicine|2014|256
The Quality of Pharmacologic Care for Vulnerable Older Patients
|Annals of Internal Medicine|2004|240